ArticleCell death & disease2024

N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.

Diaoyi Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.